Leszath Pharma, Inc. — Form D

Leszath Pharma, Inc. of SINGAPORE, U0, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-14. The offering totals $250K, of which $210K was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2020-01-14
• Form: D
• Accession: 0001799844-20-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $250K
• Amount sold: $210K
• Remaining: $40K
• Minimum investment: $10K
• Investors: 4
• Date of first sale: 2020-01-03
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-357958

Issuer

• Name: Leszath Pharma, Inc.
• CIK: 0001799844
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 74 VERDE GROVE, SINGAPORE, U0, 688606
• Phone: 65 98285176

Officers, directors & promoters (1)

More

• CIK 1799844 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search